Lisa Gill
Stock Analyst at JP Morgan
(3.47)
# 834
Out of 4,829 analysts
134
Total ratings
51.16%
Success rate
2.65%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DGX Quest Diagnostics | Maintains: Neutral | $180 → $190 | $176.96 | +7.37% | 3 | May 6, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $652 → $525 | $380.64 | +37.93% | 6 | Apr 24, 2025 | |
| CON Concentra Group Holdings Parent | Maintains: Overweight | $29 → $30 | $21.40 | +40.19% | 2 | Mar 19, 2025 | |
| OPCH Option Care Health | Maintains: Overweight | $40 → $41 | $31.84 | +28.77% | 4 | Mar 6, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $14 → $17 | $15.12 | +12.47% | 4 | Mar 6, 2025 | |
| HUM Humana | Maintains: Neutral | $257 → $256 | $249.53 | +2.59% | 6 | Feb 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $80 → $81 | $66.97 | +20.95% | 5 | Feb 18, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $142 → $145 | $148.22 | -2.17% | 6 | Feb 4, 2025 | |
| COR Cencora | Maintains: Overweight | $289 → $301 | $283.00 | +6.36% | 2 | Jan 24, 2025 | |
| PACS PACS Group | Downgrades: Neutral | $18 | $10.43 | +72.58% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $3.64 | +37.36% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $22.16 | +26.35% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $27 → $28 | $25.02 | +11.91% | 4 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $15 | $11.22 | +33.69% | 14 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $7.11 | +26.58% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $22 → $18 | $7.01 | +156.78% | 4 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $656 → $661 | $693.46 | -4.68% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $438 | $333.46 | +31.35% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $14.52 | +23.97% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $322.20 | +22.59% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $245.73 | -1.11% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $181.78 | +2.32% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $148.83 | -5.93% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $353.70 | -6.14% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $628 → $631 | $404.58 | +55.96% | 4 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.32 | +131.48% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $2.89 | +211.42% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $5.40 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $5.73 | +39.62% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $68.64 | +20.92% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $62.79 | +56.08% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $23.07 | - | 4 | Dec 19, 2017 |
Quest Diagnostics
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $176.96
Upside: +7.37%
UnitedHealth Group
Apr 24, 2025
Maintains: Overweight
Price Target: $652 → $525
Current: $380.64
Upside: +37.93%
Concentra Group Holdings Parent
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $21.40
Upside: +40.19%
Option Care Health
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $31.84
Upside: +28.77%
Alignment Healthcare
Mar 6, 2025
Maintains: Neutral
Price Target: $14 → $17
Current: $15.12
Upside: +12.47%
Humana
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $249.53
Upside: +2.59%
CVS Health
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $66.97
Upside: +20.95%
Cardinal Health
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $148.22
Upside: -2.17%
Cencora
Jan 24, 2025
Maintains: Overweight
Price Target: $289 → $301
Current: $283.00
Upside: +6.36%
PACS Group
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $10.43
Upside: +72.58%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $3.64
Upside: +37.36%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $22.16
Upside: +26.35%
Nov 29, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $25.02
Upside: +11.91%
Aug 30, 2024
Maintains: Overweight
Price Target: $20 → $15
Current: $11.22
Upside: +33.69%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $7.11
Upside: +26.58%
Aug 21, 2024
Maintains: Underweight
Price Target: $22 → $18
Current: $7.01
Upside: +156.78%
Aug 21, 2024
Maintains: Overweight
Price Target: $656 → $661
Current: $693.46
Upside: -4.68%
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $333.46
Upside: +31.35%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $14.52
Upside: +23.97%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $322.20
Upside: +22.59%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $245.73
Upside: -1.11%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $181.78
Upside: +2.32%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $148.83
Upside: -5.93%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $353.70
Upside: -6.14%
May 30, 2024
Maintains: Overweight
Price Target: $628 → $631
Current: $404.58
Upside: +55.96%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.32
Upside: +131.48%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $2.89
Upside: +211.42%
Dec 13, 2023
Downgrades: Underweight
Price Target: n/a
Current: $5.40
Upside: -
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $5.73
Upside: +39.62%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $68.64
Upside: +20.92%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $62.79
Upside: +56.08%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $23.07
Upside: -